Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

吳采虹 (Tsai-Hung Wu)

吳采虹(Tsai-Hung Wu)圖 Return Appointment First Appointment

[Profile]

  • Education
    • MD, School of Medicine, Kaohsiung Medical University,
    • PhD, Institute of Clinical Medicine, National Yang Ming University,
  • Medical Expertise
    1. Renal transplant
    2. Transplant immunology
    3. Tomm-Horsfall glycoprotein
    4. Nephrology
  • License
    License of physician, Taiwan Board of Taiwan Society of Internal Medicine Board of Taiwan Society of Nephrology
  • Language Expertise
    Mandarin Taiwanese English

[Publications]

  1. Wu TH, Li KJ, Yu CL, Tsai CY. Tamm–Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system. Molecules 2018;23(1), 200; doi: 10.3390/molecules23010200 (SCI)
  2. Liao HT, Lin MC, Tsai CY, Wu TH*. Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease: a nationwide population based study. J Chin Med Assoc 2018; 81:766-71. doi: 10.1016/j.jcma.2018.04.003 (SCI)
  3. Wu TH, Hsieh SC, Li TH, Lu CH, Liao HT, Shen CY, Li KJ, Wu CH, Kuo YM, Tsai CY, Yu CL. Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation. Biomedicines. 2022 Mar 25;10(4):773. doi:10.3390/biomedicines10040773. PMID: 35453523; PMCID: PMC9032061.
  4. Wu TH, Liao HT, Li TH, Tsai HC, Lin NC, Chen CY, Tsai SF, Huang TH, Tsai CY, Yu CL. High-Throughput Sequencing of Complementarity Determining Region 3 in the Heavy Chain of B-Cell Receptor in Renal Transplant Recipients: A Preliminary Report. J Clin Med. 2022 May 25;11(11):2980. doi:10.3390/jcm11112980. PMID: 35683373; PMCID: PMC9181060.
  5. Huang YY, Huang YH, Wu TH, Loong CC, Hsu CC, Chou YC, Chang YL. Drug-Drug Interactions with Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir-Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or Cirrhosis. Ther Drug Monit. 2022 Jun 1;44(3):377-383. doi: 10.1097/FTD.0000000000000967. PMID: 35094001.
回到最上